Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc., researches, develops, manufactures, and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. It markets its products under the Grafix, GrafixPL, Stravix, Cartiform, and BIO4 brand names. The company partners with the Department of Veteran Affairs, the Department of Defense, Howmedica Osteonics Corp., and Mesoblast Limited. Osiris Therapeutics, Inc. was founded in 1992 and is based in Columbia, Maryland. As of April 17, 2019, Osiris Therapeutics, Inc. operates as a subsidiary of Smith & Nephew plc.